The blood/fluid portion of the biorepository began operations in 2020 and has since processed approximately 400,000 biospecimens for clinical operations, epidemiologic surveillance of COVID-19, and multiple research projects.
The biorepository currently contains over 175,000 biospecimen aliquots including blood, sera, plasma, and viral transport media.
In addition to the banked specimens, which primarily focus on COVID-19, specimens can be acquired prospectively based on specific clinical characteristics derived from the electronic health record. This approach has been used to successfully validate multiple clinical assays and support Yale researchers across multiple departments.
- More than 2 million archived FFPE blocks from different diseases (all tissue types).
- Nearly 1,000 formalin-fixed autopsy tissues and associated clinical data from COVID patients (all tissue types).
- More than 3,000 RNA samples from COVID patients.
- More than 8,000 frozen saliva samples from COVID patients